Lixte Biotechnology Holdings- Warrants (01/01/2025) Current Cash

As of the most recent data (March 2026), LIXTW shows a current cash of $3.3M. That compares with $1.4M in the prior-year period — up 134.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIXTW's current cash is now $3.3M (was $1.4M) — a 134.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lixte Biotechnology Holdings- Warrants (01/01/2025) is outperforming or lagging.

Tracking LIXTW's current cash over time shows whether Lixte Biotechnology Holdings- Warrants (01/01/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.3M That compares with $1.4M in the prior-year period — up 134.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Lixte Biotechnology Holdings- Warrants (01/01/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $3.3M) with ownership activity and broader fundamentals.

Lixte Biotechnology Holdings- Warrants (01/01/2025)'s current cash is $3.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.